483 Fujian Kerui Pharmaceutical Mar 2018

483 Fujian Kerui Pharmaceutical Mar 2018

Tiara Brown-Crosen FDA$119.00 - Available Now

FDA investigators audited the Fujian Kerui Pharmaceutical - Fuqing, China facility and issued inspectional observations (via FDA 483) on 16 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Mar 2018
  • Location: Fuqing, China
  • FEI: 3003657686
Add To Cart